Orthobond Corporation Email Format

Biotechnology ResearchNew Jersey, United States11-50 Employees

Orthobond Corporation operates in biotechnology research with a focus on antibacterial surface technologies for implantable devices. Its Ostaguard platform aims to reduce bacterial contamination at the implant surface while preserving biocompatibility and device performance. The company is pursuing commercialization across several high-need clinical segments, including spinal and orthopedic procedures, breast reconstruction and aesthetic surgery, cardiac devices, neuromodulation, and hearing implants. It partners with medical device manufacturers, hospitals, and surgeons to integrate its technology into existing platforms without altering surgical workflow. Based in Monmouth Junction, New Jersey, Orthobond functions as a small to mid-sized firm within the biotechnology field. In late 2024, the company announced the appointment of George Landau as EVP of Business Development and Commercialization, signaling leadership expansion.

Sign up for free to view info

Company overview Employee directory